NBIX EPS Estimates
Neurocrine Biosciences, Inc.
$141.37
-$1.07(-0.75%)
53
Overall
70
Value
18
Tech
71
Quality
Market Cap
$14.48B
Volume
1.08M
52W Range
$122.14 - $186.12
Target Price
$206.03
NBIX EPS estimates: the consensus estimate for Neurocrine Biosciences, Inc.'s current fiscal year is $7.26 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NBIX EPS Estimates
- EPS estimate, current quarter
- $1.99
- EPS estimate, next quarter
- $2.09
- EPS estimate, current year
- $7.26
- EPS estimate, next year
- $9.46
- EPS growth, 3-year
- +44.03%
| Fiscal year | EPS |
|---|---|
| 2025 | $4.81 |
| 2024 | $3.40 |
| 2023 | $2.56 |
| 2022 | $1.61 |
| 2021 | $0.95 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBIX | $141.37 | -0.8% | 1.08M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neurocrine Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW